Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
Authors
Keywords
-
Journal
Neurotherapeutics
Volume 18, Issue 4, Pages 2397-2418
Publisher
Springer Science and Business Media LLC
Online
2021-11-12
DOI
10.1007/s13311-021-01108-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prospective, double-blind, randomized, placebo-controlled phase III study evaluating efficacy and safety of octagam 10% in patients with dermatomyositis (“ProDERM Study”)
- (2021) Rohit Aggarwal et al. MEDICINE
- Intravenous immunoglobulin response in new-onset refractory status epilepticus (NORSE) COVID-19 adult patients
- (2021) Paolo Manganotti et al. JOURNAL OF NEUROLOGY
- Intravenous immunoglobulin as the rescue treatment in NMOSD patients
- (2021) Jie Lin et al. NEUROLOGICAL SCIENCES
- Anti-SARS-CoV-2 Antibodies Within IVIg Preparations: Cross-Reactivities With Seasonal Coronaviruses, Natural Autoimmunity, and Therapeutic Implications
- (2021) Marinos C. Dalakas et al. Frontiers in Immunology
- Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial
- (2021) Christa Walgaard et al. LANCET NEUROLOGY
- Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy
- (2021) Margot Geerts et al. NEUROLOGY
- Helping the Public Understand Adverse Events Associated With COVID-19 Vaccinations
- (2021) David Dongkyung Kim et al. JAMA Neurology
- Placebo and Nocebo Effects
- (2020) Luana Colloca et al. NEW ENGLAND JOURNAL OF MEDICINE
- Treatment of MOG antibody associated disorders: results of an international survey
- (2020) D. H. Whittam et al. JOURNAL OF NEUROLOGY
- Steroid-sparing maintenance immunotherapy for MOG-IgG associated disorder
- (2020) John J. Chen et al. NEUROLOGY
- Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic disease
- (2020) Marinos C. Dalakas Neurology-Neuroimmunology & Neuroinflammation
- The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
- (2020) Naser Gharebaghi et al. BMC INFECTIOUS DISEASES
- Progress in the therapy of myasthenia gravis: getting closer to effective targeted immunotherapies
- (2020) Marinos C. Dalakas CURRENT OPINION IN NEUROLOGY
- Dramatic clinical response to ultra-high dose IVIg in otherwise treatment resistant inflammatory neuropathies
- (2020) Mahima Kapoor et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Distinct clinical and immunological features of SARS–CoV-2–induced multisystem inflammatory syndrome in children
- (2020) Pui Y. Lee et al. JOURNAL OF CLINICAL INVESTIGATION
- IVIG efficacy in CIDP patients is not associated with terminal complement inhibition
- (2019) Christian W. Keller et al. JOURNAL OF NEUROIMMUNOLOGY
- Progress in diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy
- (2019) Carina Bunschoten et al. LANCET NEUROLOGY
- Diagnosis and management of Guillain–Barré syndrome in ten steps
- (2019) Sonja E. Leonhard et al. Nature Reviews Neurology
- Scientific Advances in and Clinical Approaches to Small-Fiber Polyneuropathy
- (2019) Anne Louise Oaklander et al. JAMA Neurology
- The immunobiology of autoimmune encephalitides
- (2019) Harry Alexopoulos et al. JOURNAL OF AUTOIMMUNITY
- Clinical characterisation of sensory neuropathy with anti-FGFR3 autoantibodies
- (2019) Yannick Tholance et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Anti-Neuronal Antibodies Within the IVIg Preparations: Importance in Clinical Practice
- (2019) Maria M. Dimitriadou et al. Neurotherapeutics
- Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
- (2019) Divyanshu Dubey et al. ANNALS OF NEUROLOGY
- A randomised, multi-centre phase III study of 3 different doses of intravenous immunoglobulin 10% in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ProCID trial): Study design and protocol
- (2018) David R. Cornblath et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Subcutaneous IgG for chronic inflammatory demyelinating polyneuropathy
- (2018) Marinos C Dalakas LANCET NEUROLOGY
- Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial
- (2018) Richard Hughes et al. LANCET NEUROLOGY
- IVIg for apparently autoimmune small-fiber polyneuropathy: first analysis of efficacy and safety
- (2018) Xiaolei Liu et al. Therapeutic Advances in Neurological Disorders
- Immunotherapy in myasthenia gravis in the era of biologics
- (2018) Marinos C. Dalakas Nature Reviews Neurology
- Current practice patterns in CIDP: A cross-sectional survey of neurologists in the United States
- (2018) Deborah Gelinas et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (CIDP), a multicenter randomized double-blind placebo-controlled trial: the Path study
- (2017) I.N. van Schaik et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Subcutaneous immunoglobulin treatment in CIDP and MMN. Efficacy, treatment satisfaction and costs
- (2017) Lars H. Markvardsen et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Maintenance IV immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
- (2017) Krista Kuitwaard et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Subcutaneous immunoglobulin in myasthenia gravis exacerbation
- (2017) Grayson Beecher et al. NEUROLOGY
- A phase 3 trial of IV immunoglobulin for Alzheimer disease
- (2017) Norman R. Relkin et al. NEUROLOGY
- Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System
- (2017) Josep Dalmau et al. PHYSIOLOGICAL REVIEWS
- Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity
- (2015) Isaak Quast et al. JOURNAL OF CLINICAL INVESTIGATION
- Autoimmune antigenic targets at the node of Ranvier in demyelinating disorders
- (2015) Panos Stathopoulos et al. Nature Reviews Neurology
- Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
- (2015) Jan D. Lünemann et al. Nature Reviews Neurology
- Efficacy of Intravenous Immunoglobulin in Neurological Diseases
- (2015) Jan D. Lünemann et al. Neurotherapeutics
- Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis
- (2015) Jeffrey T. Guptill et al. Neurotherapeutics
- Inflammatory Muscle Diseases
- (2015) Marinos C. Dalakas NEW ENGLAND JOURNAL OF MEDICINE
- Mechanistic Effects of IVIg in Neuroinflammatory Diseases: Conclusions Based on Clinicopathologic Correlations
- (2014) Marinos C. Dalakas JOURNAL OF CLINICAL IMMUNOLOGY
- IVIg in the chronic management of myasthenia gravis: Is it enough for your money?
- (2014) Marinos C. Dalakas JOURNAL OF THE NEUROLOGICAL SCIENCES
- Subcutaneous IgG in neurologic diseases
- (2013) Melvin Berger Immunotherapy
- Subcutaneous immunoglobulin therapy for inflammatory neuropathy: current evidence base and future prospects
- (2013) Y. A. Rajabally JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Serum IgG levels in IV immunoglobulin treated chronic inflammatory demyelinating polyneuropathy
- (2013) K. Kuitwaard et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Maintenance IVIg therapy in myasthenia gravis does not affect disease activity
- (2013) M.A. Hellmann et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy
- (2013) Angelika F. Hahn et al. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM
- Provision of an explanation for the inefficacy of immunotherapy in sporadic inclusion body myositis: Quantitative assessment of inflammation and β-amyloid in the muscle
- (2012) Jana Zschüntzsch et al. ARTHRITIS AND RHEUMATISM
- Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
- (2012) H. S. Patwa et al. NEUROLOGY
- Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
- (2012) Erwin W. Gelfand NEW ENGLAND JOURNAL OF MEDICINE
- Advances in the diagnosis, pathogenesis and treatment of CIDP
- (2011) Marinos C. Dalakas Nature Reviews Neurology
- Timing and Course of Clinical Response to Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- (2010) Norman Latov ARCHIVES OF NEUROLOGY
- Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg)
- (2010) T. VASSILEV et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy
- (2009) Marinos C. Dalakas et al. ANNALS OF NEUROLOGY
- Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome
- (2009) Krista Kuitwaard et al. ANNALS OF NEUROLOGY
- Clinical applications of intravenous immunoglobulins in neurology
- (2009) R. A. C. Hughes et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV
- (2009) Vera Bril et al. MUSCLE & NERVE
- Health-related quality-of-life improvements in CIDP with immune globulin IV 10%: The ICE Study
- (2009) I.S.J. Merkies et al. NEUROLOGY
- Impaired inhibitory Fc receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy
- (2009) B. Tackenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy
- (2008) Giuseppe Plazzi et al. JOURNAL OF NEUROLOGY
- Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial
- (2008) Richard AC Hughes et al. LANCET NEUROLOGY
- Identification of a receptor required for the anti-inflammatory activity of IVIG
- (2008) R. M. Anthony et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Recapitulation of IVIG Anti-Inflammatory Activity with a Recombinant IgG Fc
- (2008) R. M. Anthony et al. SCIENCE
- Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients
- (2007) J-M Leger et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation